Indication
Squamous cell carcinoma of the anal canal
Squamous cell carcinoma of the anal canal is a malignant epithelial neoplasm arising from the mucosal lining of the lower gastrointestinal tract between the anorectal junction and the anal verge. Read more about Squamous cell carcinoma of the anal canal
1 drugs 1 manufacturers
Drugs that treat it
Common Squamous cell carcinoma of the anal canal therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSquamous cell carcinoma of the anal canal is a malignant epithelial neoplasm arising from the mucosal lining of the lower gastrointestinal tract between the anorectal junction and the anal verge.
It represents the vast majority of primary anal malignancies, predominantly driven by high-risk oncogenic human papillomavirus infection—particularly types 16 and 18—with elevated risk among individuals who are immunocompromised, living with HIV, or active smokers.
Pathophysiologically, persistent viral oncoprotein activity leads to dysplastic squamous changes that progress into invasive carcinoma, commonly manifesting clinically with rectal bleeding, anal pain, a palpable mass, pruritus, or altered bowel habits.
- nih.gov
Squamous cell carcinoma of the anal canal is a malignant epithelial neoplasm arising from the mucosal lining of the lower gastrointestinal tract between the anorectal junction and the anal verge It represents the vast majority of primary anal malignancies, predominantly driven by high-risk oncogenic human papillomavirus infection—particularly types 16 and 18—with elevated risk among individuals who are immunocompromised, living with HIV, or active smokers Pathophysiologically, persistent viral o...
- cancer.gov
Squamous cell carcinoma of the anal canal is a malignant epithelial neoplasm arising from the mucosal lining of the lower gastrointestinal tract between the anorectal junction and the anal verge
- pennmedicine.org
Squamous cell carcinoma of the anal canal is a malignant epithelial neoplasm arising from the mucosal lining of the lower gastrointestinal tract between the anorectal junction and the anal verge
- nih.gov
It represents the vast majority of primary anal malignancies, predominantly driven by high-risk oncogenic human papillomavirus infection—particularly types 16 and 18—with elevated risk among individuals who are immunocompromised, living with HIV, or active smokers Pathophysiologically, persistent viral oncoprotein activity leads to dysplastic squamous changes that progress into invasive carcinoma, commonly manifesting clinically with rectal bleeding, anal pain, a palpable mass, pruritus, or alte...
Personalize your experience
Follow Squamous cell carcinoma of the anal canal and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.